Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Somatuline
Pharma
Ipsen CEO 'not at all afraid' of Big Pharma in rare diseases
Ipsen is "agnostic" in terms of rare disease indications, but there’s one field CEO David Loew doesn't want to enter just yet.
Angus Liu
Jan 18, 2023 10:55am
Dire straits detailed for Epizyme before buyout by Ipsen
Jul 13, 2022 8:46am
Ipsen snaps up Epizyme and cancer drug Tazverik for $247M
Jun 27, 2022 10:20am
Ipsen starts $66M Somatuline autoinjector project
Mar 21, 2022 7:35am
